** Shares of medical cannabis developer Creso Pharma
CPH.AX fall as much as 31.7% to A$0.14, hitting an all-time
low
** Co's shares, which had been on trading halt since Nov. 1,
resume trading after its proposed acquisition by PharmaCielo Ltd
PCLO.V was mutually terminated on Nov. 12 urn:newsml:reuters.com:*:nASX49Dwdd
** Co has secured convertible debt and share placement
financing; currently exploring strategic partnerships
urn:newsml:reuters.com:*:nASX6GxRWY
** Over 11 mln shares change hands, compared with the 30-day
average volume of ~230,000
** Stock down 58% this year, as of last close
(Reporting by Arundhati Dutta)
((Arundhari.dutta@thomsonreuters.com))